ARIA ARIAD Pharmaceuticals, Inc.

NSD
$26.36

ARIAD Pharmaceuticals, Inc. (ARIA) is expected to report earnings on October 5, 2026, before the market open.

Earnings Date
Oct 5
Monday · 7:35 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About ARIAD Pharmaceuticals, Inc.

ARIAD Pharmaceuticals Inc is an oncology company. The Company is engaged in transforming the lives of cancer patients with breakthrough medicines. It commercializes & develops products and product candidates including Iclusig, Brigatinib, and AP32788.

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.